Susquehanna International Group
CRVO icon

Susquehanna International Group’s CervoMed CRVO Stock Holding History

Susquehanna International Group’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,075
Closed -$82.2K – 12601
2025
Q2 		$82.2K Buy
+13,075
New +$111K ﹤0.01% 11899
2021
Q1 		– Sell
-292
Closed -$17K – 12306
2020
Q4 		$17K Buy
292
+90
+45% +$5.27K ﹤0.01% 10895
2020
Q3 		$13K Buy
+202
New +$15.4K ﹤0.01% 10403
2020
Q2 		– Sell
-154
Closed -$4K – 10208
2020
Q1 		$4K Buy
+154
New +$4.67K ﹤0.01% 10114

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Susquehanna International Group's CRVO Position: Q3 2025 in Review

Susquehanna International Group sold out of CervoMed (CRVO) in Q3 2025, closing a stake of 13,075 shares — an estimated $82.2K sold.

Susquehanna International Group first reported a position in CRVO in Q1 2020 and held it in 4 quarters. The position peaked at $82.2K in Q2 2025. 45 funds tracked by Wall St. Rank hold CRVO as of Q3 2025.

  • Susquehanna International Group reported no remaining CervoMed position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 13,075 CervoMed shares in Q3 2025, an estimated $82.2K.
  • Susquehanna International Group first reported a position in CervoMed in Q1 2020 and held it in 4 quarters.
  • Susquehanna International Group's CervoMed position peaked at $82.2K in Q2 2025.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.